Results 11 to 20 of about 61,992 (218)

Relationship Between Ankylosing Spondylitis and Cerebrovascular Disorders: A Systematic Review

Eurasian Journal of Medicine
Cerebrovascular events are linked to ankylosing spondylitis. Accelerated atherosclerosis and endothelial dysfunction against a backdrop of inflammation have been widely blamed for the increased cerebrovascular risk in ankylosing spondylitis.
Mohammad Mahdi Heidari, Azad Khaledi, Amir Mohammad Taravati, Ali Rastegar-Kashkouli, Farzaneh Moammer, Iman Saffar   +5 more
doaj   +2 more sources

Clinical study of patient with Ankylosing Spondylitis

Journal of Pharmacopuncture, 2006
Object : This study is designed in order to evaluate oriental medical treatment of ankylosing spondylitis. Methods : The authors observed patient by ROM & VAS for operated acupuncture treatment, herbal medicine treatment and physiotherapy Conclusion :
Lee Jae-Min, Hong Kwon-eui
doaj   +2 more sources

Erectile dysfunction in ankylosing spondylitis patients

International Brazilian Journal of Urology
Background Rheumatic diseases such as ankylosing spondylitis (AS) may be associated with sexual dysfunction. Aim To study erectile function of a group of Brazilian AS patients comparing them with controls.
Thiago Santana, Thelma Skare, Vitor Steil Delboni, Juliana Simione, Ana Paula B. Campos, Renato Nisihara   +5 more
doaj   +2 more sources

Biomarkers of response to therapy in Ankylosing Spondylitis [PDF]

, 2013
Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine which leads to progressive spinal fusion and deformity. With improvements in MRI, this condition is now being recognized earlier.
Pathan, Ejaz Mohammed Ishaq
core   +1 more source

Persistent clinical efficacy and safety of anti-tumour necrosis factor \textgreeka therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response [PDF]

, 2008
Background: There is insufficient evidence for the long-term efficacy and safety of anti-tumour necrosis factor therapy in patients with ankylosing spondylitis (AS).
Baraliakos, X., Sieper, J., Zeidler, H., Braun, J., Listing, J., Schewe, Stefan, Burmester, G., Sörensen, H., Krause, A., Schneider, M., Fritz, C., Alten, R.   +11 more
core   +1 more source

Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis

BMC Musculoskeletal Disorders, 2007
Background Ankylosing spondylitis is a chronic inflammatory rheumatic disorder which usually begins in early adulthood. The diagnosis is often delayed by many years.
Hodler Juerg, Kissling Rudolf O, Pfirrmann Christian WA, Weber Ulrich, Zanetti Marco   +4 more
doaj   +1 more source

ASAS/EULAR recommendations for the management of ankylosing spondylitis [PDF]

, 2006
Objective: To develop evidence based recommendations for the management of ankylosing spondylitis (AS) as a combined effort of the `ASsessment in AS' international working group and the European League Against Rheumatism.Methods: Each of the 22 ...
Sieper, J., Sturrock, R.D., Böhm, H., van Royen, B. J., Pavelka, K, Inman, R.D., Burgos-Vargas, R., Géher, P., Collantes, E, Braun, J., Kvien, TK, Davis Jr., J. C., Kvien, T.K., Leirisalo-Repo, M., Stucki, G., Khan, M.A., Geher, P, Davis, JC, Dijkmans, B., Pavelka, K., Sturrock, RD, Davis, J. C., Stucki, G, van der Heijde, D., Kvien, T. K., Zochling, J., Olivieri, I., Dougados, M, Leirisalo-Repro, M, Wendling, D., Dougados, M., Inman, R. D., Burgos-Vargas, R, Sieper, J, Collantes, E., Dijkmans, B, Olivieri, I, Bohm, H, Zo, Khan, MA, van der, LS, van Royen, BJ, Renseigné, Non, van der, HD, Khan, M. A., Wendling, D, Inman, RD, van der Linden, S., Braun, J, Géher, R. D. and Khan, Sturrock, R. D.   +50 more
core   +1 more source

Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis

Genome Biology, 2017
Background The assessment and characterization of the gut microbiome has become a focus of research in the area of human autoimmune diseases. Ankylosing spondylitis is an inflammatory autoimmune disease and evidence showed that ankylosing spondylitis may
Chengping Wen, Zhijun Zheng, Tiejuan Shao, Lin Liu, Zhijun Xie, Emmanuelle Le Chatelier, Zhixing He, Wendi Zhong, Yongsheng Fan, Linshuang Zhang, Haichang Li, Chunyan Wu, Changfeng Hu, Qian Xu, Jia Zhou, Shunfeng Cai, Dawei Wang, Yun Huang, Maxime Breban, Nan Qin, Stanislav Dusko Ehrlich   +20 more
doaj   +1 more source

ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health [PDF]

, 2010
Objective: To report on the results of a standardised consensus process agreeing on concepts typical and/or relevant when classifying functioning and health in patients with ankylosing spondylitis (AS) based on the International Classification of ...
Stucki, Gerold, van der Horst Bruinsma, I. E., Kostanjsek, Nenad, Maksymowych, W.P., Maksymowych, W., Boonen, A., Braun, J., Bruinsma, I.E.V., Huang, F., Cieza, A., van der Horst Bruinsma, I.E., van der Heijde, D., Bruinsma, I. E. van der Horst, Heijde, D. van der, Cieza, Alarcos, Kostanjsek, N., Huang, Fan, Stucki, G.   +17 more
core   +1 more source

Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of Ankylosing Spondylitis [PDF]

, 2013
Technology: Infliximab and comparator biological such as adalimumab, etanercept, golimumab. Conditions: Ankylosing spondylitis (AS) Issue: Infliximab is registered to be used in patients with AS.
Péntek, Márta
core   +1 more source